Found 568 matching trials
Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia(R/R-ALL)
PHASE2The purpose of this study is to evaluate the safety and efficacy of IFN-α c...
Location
The First Affiliated Hospital of Soochow University
A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors
PHASE1This clinical study is to investigate the safety and tolerability of CAR mo...
Location
Shanghai Zhongshan Hospital
A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors
PHASE1This is a single-center, open-label clinical study of anti-HER2-CAR-T cells...
Location
Phase I Clinical Trials Center Of The First Hospital of China Medical University
An Exploratory Study by Fast CAR T Cells
EARLY_PHASE1The main goal of this trial is to evaluate the safety and tolerability of C...
Location
Shanghai Mengchao Cancer Hospital
PD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate Cancer
PHASE1PD1-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer...
Location
The First Affiliated Hospital, Zhejiang University
UTAA17 Injection in the Treatment of Relapsed/Refractory Multiple Myeloma
NAThe clinical trial was designed as a single-arm, open-label clinical study,...
Location
The Second Affiliated Hospital of Soochow University
UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases
EARLY_PHASE1This is a single-arm, open-label, investigator-initiated trial (IIT) design...
Location
Union Hospital, Tongji Medical College, Huazhong University of Science & Technology
Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy
PHASE1This is a multicenter Phase 1b study evaluating the safety, tolerability, a...
CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma.
PHASE1This is a first-in-human trial proposed to test CD19-specific CAR-T cells w...
The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis
PHASE1This study is a single-center, open-label, single-arm, dose-exploration stu...
Status
Active Not Recruiting
Location
The Second Affiliated Hospital of Air Force Medical University